Patient-Centered Communication During Chemotherapy

化疗期间以患者为中心的沟通

• 批准号: 7127310
• 负责人: DOUGLAS M POST
• 金额: $ 11.68万
• 依托单位: OHIO STATE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-09-29 至 2008-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7127310
• 关键词: behavioral /social science research tag; breast neoplasms; cancer rehabilitation /care; clinical research; communication; computer assisted patient care; depression; education evaluation /planning; fatigue; female; health education; health services research tag; human subject; neoplasm /cancer chemotherapy; pain; patient care personnel relations; patient oriented research; personal computers; therapy adverse effect; training; behavioral /social science research tag; breast neoplasms; cancer rehabilitation /care; clinical research; communication; computer assisted patient care; depression; education evaluation /planning; fatigue; female; health education; health services research tag; human subject; neoplasm /cancer chemotherapy; pain; patient care personnel relations; patient oriented research; personal computers; therapy adverse effect; training

DESCRIPTION (provided by applicant): Pain, depression, and fatigue are among the most common disease and treatment-related symptoms experienced by cancer patients. Studies have indicated that communication problems between cancer patients and clinicians are a major barrier to the effective management of these symptoms. This project is designed to address this important problem through the development and evaluation of a PDA-based patient communication intervention for breast cancer patients undergoing chemotherapy treatment. The intervention will be comprised of two integrated components: symptom monitoring and tailored patient communication training. Patients will be asked to complete fatigue, depression, and pain inventories on a PDA at the beginning of chemotherapy and once per week through the completion of treatment. On the day prior to an appointment for chemotherapy treatment, a summary of fatigue, depression, and pain scores will be integrated with a tailored patient communication skills training program and displayed on the PDA for patient viewing. Patients will be taught, through role modeling, how to effectively communicate the types of symptoms they have experienced between treatments. They will also be encouraged to bring the PDA with their symptom summaries to each chemotherapy visit and to share this information with their health care provider. Year one of the project will primarily be devoted to the development and usability testing of the intervention. A feasibility trial will be conducted during the second year. Fifty patients with breast cancer will be recruited into the trial at the start of their chemotherapy treatment. A repeated measures design will be used to assess the effects of the intervention on symptoms of fatigue, depression, and pain over the course of treatment. At the end of treatment, focus groups will be conducted with study participants to assess their responses to the intervention and their perceptions of the system's value to both themselves and future cancer patients. In addition, the feasibility of the project, defined as the proportion of patients recruited into the study and the proportion of patient adherence to instructed use of the system, will be analyzed. Specific aims of the project include: 1) Develop the patient-centered communication intervention; 2) Conduct usability testing to ensure the successful completion of the intervention; 3) Examine study feasibility and patient reactions to the intervention; and 4) Evaluate intervention effects on pain, depression, and fatigue symptoms over time.

描述（由申请人提供）：疼痛，抑郁和疲劳是癌症患者经历的最常见疾病和治疗相关症状之一。 研究表明，癌症患者和临床医生之间的交流问题是对这些症状有效管理的主要障碍。 该项目旨在通过开发和评估接受化学疗法治疗的乳腺癌患者的患者交流干预措施来解决这一重要问题。 干预措施将由两个综合组件组成：症状监测和量身定制的患者沟通培训。 将要求患者在化学疗法开始时在PDA上完成疲劳，抑郁和疼痛清单，并在完成治疗后每周一次。 在预约化学疗法治疗的前一天，疲劳，抑郁和疼痛评分的摘要将与量身定制的患者沟通技巧培训计划集成，并在PDA上显示以供患者观察。 通过角色建模将教患者如何有效地传达他们在治疗之间经历的症状类型。 还将鼓励他们将PDA带有症状摘要，并参观每次化疗，并与他们的医疗保健提供者分享此信息。 该项目的第一年将主要致力于对干预措施的开发和可用性测试。 第二年将进行可行性试验。 在化学疗法治疗开始时，将将五十例乳腺癌患者招募到试验中。 重复的措施设计将用于评估干预措施对治疗过程中疲劳，抑郁和疼痛症状的影响。 在治疗结束时，将与研究参与者一起进行焦点小组，以评估他们对干预措施的反应以及对系统对自己和未来癌症患者的价值的看法。 此外，将分析该项目的可行性，该项目将分析为研究中招募的患者比例以及患者依从性使用该系统的比例。 该项目的具体目的包括：1）开发以患者为中心的沟通干预； 2）进行可用性测试以确保成功完成干预措施； 3）检查研究可行性和患者对干预措施的反应； 4）评估干预对疼痛，抑郁和疲劳症状的影响。